Literature DB >> 8115736

Wound complications in pars plana vitrectomy.

A E Kreiger1.   

Abstract

Eighteen eyes with examples of clinically important wound-related complications are reported. These include hemorrhage, fibrous ingrowth, and tractional or mechanical problems. Wound hemorrhages may occur early or late and can be the cause of substantial morbidity. Furthermore, intraocular blood is undesirable because it may provoke cataract formation, contribute to the postvitrectomy fibrin syndrome, induce fibrovascular proliferation, and lead to further surgery to remove the blood. Fibroplasia at the wound sites may in some patients contribute to the development of anterior hyaloid fibrovascular proliferation. Fibrous ingrowth may occur early or late and may be self-limited, with few side effects, or florid, with progression to retinal detachment or phthisis bulbi. Dilation of subconjunctival blood vessels entering the incision site suggests the presence of fibrous ingrowth or fibrovascular proliferation occurring in the vitreous base. Tractional or mechanical problems include retinal breaks, which may or may not lead to retinal detachment, and scarring within the vitreous base, which may contribute to the formation of anterior vitreoretinal traction or anterior proliferative vitreoretinopathy.

Entities:  

Mesh:

Year:  1993        PMID: 8115736     DOI: 10.1097/00006982-199313040-00012

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  17 in total

1.  Retinal detachment after posterior segment intraocular foreign body injuries.

Authors:  A M El-Asrar; S A Al-Amro; N M Khan; D Kangave
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Pars plana placement of Ahmed glaucoma valve tube through sclerotomy port in refractory glaucoma: A novel surgical technique.

Authors:  Richa Gupta; Abhishek Varshney
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

3.  360-degree intra-operative laser retinopexy for the prevention of retinal re-detachment in patients treated with primary pars plana vitrectomy.

Authors:  Ali Dirani; Fares Antaki; Marc-André Rhéaume; Danny Gauthier; Louis Corriveau; Jean-Daniel Arbour; Karim Hammamji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-26       Impact factor: 3.117

4.  Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.

Authors:  J F West; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

5.  Pars plana incisions of four patients: histopathology and electron microscopy.

Authors:  F H Koch; A E Kreiger; M Spitznas; B Glasgow; R Y Foos; M O Yoshizumi
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

6.  The management of wound-related complications in pars plana vitrectomy.

Authors:  A E Kreiger
Journal:  Trans Am Ophthalmol Soc       Date:  1994

7.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

8.  Combining robot-assisted surgical system and 3D visualization system for teaching minimally invasive vitreoretinal surgery.

Authors:  Yi-Qi Chen; Dan Cheng; Lin Zhu; Wei-Qian Gao; Jia-Feng Yu; Jun Wang; Xin-Yi Deng; Ji-Wei Tao; Jia Qu; Li-Jun Shen
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

9.  Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.

Authors:  Morteza Entezari; Alireza Ramezani; Hamid Ahmadieh; Pejman Bakhtiari; Mehdi Yaseri; Kian Soltani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-25       Impact factor: 3.117

10.  Pseudophakic retinal detachment: anatomic and visual results.

Authors:  P Girard; I Karpouzas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.